Adrenalitis

The Autoimmune Diseases, Fourth Edition

Volumn , Issue , 2006, Pages 501,XV-514,XVI

  Betterle, Corrado ^a   Zanchetta, Renato ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49549085143     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012595961-2/50040-8     Document Type: Chapter

References (145)

1. T. Addison (1868) On the constitutional and local effects of disease of the suprarenal capsules. In a collection of the published writings of the late Thomas Addison MD, physician to Guy's Hospital. London: New Sydenham Society
2. P. Albergoni, M.V. Gazzola, E. Slanzi, C. Carcassi, C. Dal Pra, A. Moscon and C. Betterle (2003) HLA-DR and DQ associations with autoimmune Addison's disease in Italian patients. Genes Immun. 4(Suppl. 1), S35.
3. J.R. Anderson, R.B. Goudie, K.G. Gray and G.C. Timbury (1957) Autoantibodies in Addison's disease. Lancet 1 1123-1124.
4. J.U. Anderson, R.B. Goudie, K. Gray and D.A. Stuart Smith (1968) Immunological features of idiopathic Addison's disease: an antibody to cells producing steroid hormones. Clin. Exp. Immunol. 3 107-117.
5. J.A. Andrada, F.R. Skelton, E.C. Andrada, F. Milgrom and E. Witebsky (1968) Experimental autoimmune adrenalitis in rats. Lab. Invest. 19 460-465.
6. S. Arif, S. Vallian, F. Farzaneh, M.M. Zanone, S.L. James, M. Pietropaolo, S. Hettiarachchi, D. Vergani, G.S. Conway and M. Peakman (1996) Identification of 3-beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J. Clin. Endocrinol. Metab. 81 4439-4445.
7. W. Arlt and B. Allolio (2003) Adrenal insufficiency. Lancet 361 1881-1893.
8. T. Asawa, N. Wedlock, A. Baumann-Antczak, B. Rees Smith and J. Furmaniak (1994) Naturally occurring mutations in human steroid 21-hydroxylase influence adrenal autoantibody binding. J. Clin. Endocrinol. Metab. 79 372-376.
9. R.J. Auchus and W.L. Miller (2001) The principles, pathways and enzymes of human steroidogenesis. L.J. DeGroot, J.L. Jameson (Eds) 4th ed. Endocrinology vol. 2 Philadelphia: W.B. Saunders
10. E.V. Barnett, D.C. Dumonde and L.E. Glynn (1963) Induction of autoimmunity to adrenal gland. Immunology 6 382.
11. A. Baumann-Antczak, N. Wedlock, J. Bednarek, Y. Kiso, H. Krishnan, S. Fowler, B. Rees Smith and J. Furmaniak (1992) Autoimmune Addison's disease and 21-hydroxylase. Lancet 340 429-430.
12. P.E. Beales, F. Castri, A. Valiani, G. Rosignoli, L. Buckley and P. Pozzilli (2002) Adrenalitis in the non-obese diabetic mouse. Autoimmunity 35(5), 329-333.
13. J. Bednarek, J. Furmaniak, N. Wedlock, Y. Kiso, A. Baumann-Antczak, S. Fowler, H. Krishnan, J.A. Craft and B. Rees Smith (1992) Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS Lett. 309 51-55.
14. C. Betterle (2004) Addison's disease and autoimmune polyglandular syndromes. V. Geenen, G. Chrosus (Eds) Immunoendocrinology in Health and Disease New York: Marcel Dekker
15. C. Betterle and M. Volpato (1998) Adrenal and ovarian autoimmunity. Eur. J. Endocrinol. 138 16-25.
16. C. Betterle, C. Scalici, F. Presotto, B. Pedini, L. Moro, F. Rigon and F. Mantero (1988) The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J. Endocrinol. 117 467-475.
17. C. Betterle, A. Rossi, S. Dalla Pria, L. Artifoni, B. Pedini, S. Gavasso and A. Caretto (1993) Premature ovarian failure: autoimmunity and natural history of the disease. Clin. Endocrinol. 39 35-43.
18. C. Betterle, M. Volpato, B. Rees Smith, J. Furmaniak, S. Chen, N.A. Greggio, M. Sanzari, F. Tedesco, B. Pedini, M. Boscaro and F. Presotto (1997) I. adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J. Clin. Endocrinol. Metab. 82 932-938.
19. C. Betterle, M. Volpato, B. Rees Smith, J. Furmaniak, S. Chen, R. Zanchetta, N.A. Greggio, B. Pedini, M. Boscaro and F. Presotto (1997) II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J. Clin. Endocrinol. Metab. 82 939-942.
20. C. Betterle, M. Volpato, B. Pedini, S. Chen, B. Rees Smith and J. Furmaniak (1999) Adrenal-cortex autoantibodies and steroid producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays. J. Clin. Endocrinol. Metab. 84(2), 618-622.
21. C. Betterle, C. Dal Pra, F. Mantero and R. Zanchetta (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr. Rev. 23 327-364.
22. C. Betterle (2004) Addison's disease and autoimmune polyglandular syndromes. V. Geenen, G. Chrousos (Eds) Immunoendocrinology in health and disease NY: M. Dekker
23. C. Betterle, G. Coco and R. Zanchetta (2005) Adrenal cortex autoantibodies in subjects with normal adrenal function. Best. Pract. Res. Clin. Endocrinol. Metab. 19 85-99.
24. R.M. Blizzard and M. Kyle (1963) Studies on adrenal antigens and autoantibodies in Addison's disease. J. Clin. Invest. 42 1653-1660.
25. M. Boscaro, C. Betterle, M. Volpato, F. Fallo, J. Furmaniak, B. Rees Smith and N. Sonino (1996) Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. J. Clin. Endocrinol. Metab. 81 2801-2804.
26. W.M. Burch (1982) Urine free-cortisol determination: a useful tool in the management of chronic hypoadrenal states. JAMA 247 2002-2004.
27. Casserius, J. Tabulae Anatomicae LXXIIX, West Germany: Druckerei Holzer, Copy 1283.
28. Q.J. Chen, M.S. Lan, J.X. She and N.K. Maclaren (1998) The gene responsible for autoimmune polyglandular syndrome type 1 maps to chromosome 21q22.3 in US patients. J. Autoimmun. 11 117-183.
29. S. Chen, J. Sawicka, C. Betterle, M. Powell, L. Prentice, M. Volpato, B. Rees Smith and J. Furmaniak (1996) Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease and premature ovarian failure. J. Clin. Endocrinol. Metab. 83 2977-2986.
30. B.C. Chung, K.J. Matteson, R. Voutilainen, T.K. Mohandas and W.L. Miller (1986) Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. Proc. Natl Acad. Sci. USA 83 8962-8966.
31. M.G. Clemente, P. Obermyer-Straub, A. Meloni, C.P. Strassburg, V. Arangino, R.H. Tukey, S. De Virgilis and M.P. Manns (1997) Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J. Clin. Endocrinol. Metab. 82 1353-1361.
32. M.G. Clemente, A. Meloni, P. Obermyer-Straub, F. Frau, M.P. Manns and S. De Virgilis (1998) Two cytochrome P450 are major hepato-cellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology 114 324-328.
33. J. Colls, C. Betterle, M. Volpato, B. Rees Smith and J. Furmaniak (1995) A new immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in Addison's disease. Clin. Chem. 41 375-380.
34. J. Colover and L.E. Glynn (1958) Experimental iso-immune adrenalitis. Immunology 2 172-178.
35. C. Dal Pra, S. Chen, C. Betterle, R. Zanchetta, V. McGrath, J. Furmaniak and B. Rees Smith (2004) Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase. Eur. J. Endocrinol. 150 313-321.
36. A. De Bellis, A. Bizzarro, R. Rossi, V.A. Paglionico, T. Criscuolo, G. Lombardi and A. Bellastella (1993) Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies. J. Clin. Endocrinol. Metab. 76 1002-1007.
37. J.L. Doppman (2001) Adrenal imaging. L.J. DeGroot, J.L. Jameson (Eds) 4th ed. Endocrinology vol. 2 Philadelphia: W.B. Saunders
38. G.L. Duff and C. Bernstein (1933) Five cases of Addison's disease with so-called atrophy of the adrenal cortex. Bull. Johns Hopkins Hosp. 52 67.
39. D. Dunlop (1963) Eighty-six cases of Addison's disease. Br. Med. J. 3 887-891.
40. K.J. Dunn and M.E. Herrtage (1998) Hypocortisolaemia in a Labrador retriever. J. Small Anim. Pract. 39 90-93.
41. M.J. Drury, D.M. Keelan, F.J. Timoney and W.J. Irvine (1979) Case report Juvenile familial endocrinopathy. Clin. Exp. Immunol. 7 125-132.
42. R.J. Eason, M.S. Croxon, M.C. Perry and S.D. Somerfield (1982) Addison's disease, adrenal autoantibodies and computerized adrenal tomography. NZ Med. J. 95 569-573.
43. O. Ekwall, H. Hedstrand, L. Grimelius, J. Haavik, J. Perheentupa, J. Gustafsson, E. Husebye, O. Kämpe and F. Rorsman (1998) Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352 279-283.
44. O. Ekwall, K. Sjoberg, R. Mirakian, F. Rorsman and O. Kampe (1999) Tryptophan hydroxylase autoantibodies and intestinal disease in autoimmune polyendocrine syndrome type 1. Lancet 354 568.
45. B. Eustachius (1564) Opuscula anatomica de renum structura, efficio et adminstratione, Venice: V. V. Luchino.
46. A. Falorni, A. Nikoshokov, S. Laureti, E. Grenbäck, A.L. Hulting and G. Casucci (1995) High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J. Clin. Endocrinol. Metab. 80 2752-2755.
47. A. Falorni, S. Laureti, A. Nikoshkov, et al. (1997) 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Clin. Exp. Immunol. 107 341-346. for the Belgian Diabetes Registry
48. W.J. Fidler (1977) Ovarian thecal metaplasma in adrenal glands. Am. J. Clin. Pathol. 67 318-322.
49. F. Fogt, A.O. Vortmeyer, C. Poremba, M. Minda, C.A. Harris and J.E. Tomaszewski (1998) Bcl2 expression in normal adrenal glands and in adrenal neoplasms. Mod. Pathol. 11 716-720.
50. M. Freeman and A.P. Weetman (1992) T and B cell reactivity to adrenal antigens in autoimmune Addison's disease. Clin. Exp. Immunol. 88 275-279.
51. Y. Fujii, N. Kato, J. Kito, J. Asai and T. Yokochi (1992) Experimental autoimmune adrenalitis: a murine model for Addison's disease. Autoimmunity 12 47-52.
52. J. Furmaniak and B. Rees Smith (2002) Addison's disease. R.G. Gill (Eds) Immunologically Mediated Endocrine Diseases Philadelphia: Lippincott Williams and Williams
53. J. Furmaniak, D. Talbot, D. Reinwein, G. Benker, F.M. Creag and B. Smith (1988) Immunoprecipitation of human adrenal microsomal antigen. FEBS Lett. 232 25-28.
54. J. Furmaniak, S. Kominani, T. Asawa, N. Wedlock, J. Colls and B. Rees Smith (1994) Autoimmune Addison's disease. Evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency. J. Clin. Endocrinol. Metab. 79 1517-1521.
55. J. Furmaniak, J. Sanders and B. Rees Smith (1999) Autoantigens in the autoimmune endocrinopathies. R. Volpé (Eds) Contemporary Endocrinology: Autoimmune Endocrinopathies Totowa, NJ: Humana Press
56. J.A. Gonzalez-Hernandez, S.R. Bornstein, M. Ehrhart-Bornestein, E. Spath-Scwalbe, G. Jirikowski and W.A. Scherbaum (1994) Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a pancreatic or autocrine regulation of adrenal function. J. Clin. Endocrinol. Metab. 79 1492-1497.
57. S.K. Grinspoon and B.M. Biller (1994) Clinical review 62: laboratory assessment of adrenal insufficiency. J. Clin. Endocrinol. Metab. 79 923-931.
58. R.W. Groves, G.C. Toms, B.J. Houghton and J.P. Monson (1988) Corticosteroid replacement therapy: twice or thrice daily? J. R. Soc. Med. 81 514-516.
59. P.H. Guttman (1930) Addison's disease: statistical analysis of 566 cases and study of the pathology. Arch. Pathol. 10 742-895.
60. B.W. Harlton (1976) Addison's disease in a dog. Vet. Med. Small Anim. Clin. 71 285-288.
61. Y. Hayashi, T. Hiyoshi, T. Takemura, C. Kurashima and K. Hirokawa (1989) Focal lymphocytic infiltration in the adrenal cortex of the elderly: immunohistochemical analysis of infiltrating lymphocytes. Clin. Exp. Immunol. 77 101-105.
62. H. Hedstrand, O. Ekwall, J. Haavik, E. Landgren, C. Betterle, J. Perheentupa, J. Gustafsson, E. Husebye, F. Rorsman and O. Kämpe (2000) Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome Type 1. Biochem. Biophys. Res. Commun. 267 456-461.
63. H. Hedstrand, O. Ekwall, M.J. Olsson, E. Landgren, H.E. Kemp, A. Weetman, J. Perheentupa, E. Husebye, J. Gustafsson, C. Betterle, O. Kampe and F. Rorsman (2001) The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type 1. J. Biol. Chem. 276 35390-35395.
64. S.C. Henzen-Logmans, H.V. Stel, G.N. Van Muijen, H. Mullink and C.J. Meijer (1988) Expression of intermediate filament protein in adrenal cortex and related tumors. Histopathology 12 359-372.
65. J.R. Hiatt and N. Hiatt (1997) The conquest of Addison's disease. Am. J. Surg. 174 280-283.
66. A. Hoek, J. Schoemaker and H.A. Drexhage (1997) Premature ovarian failure and ovarian autoimmunity. Endocr. Rev. 18 107-134.
67. E.M. Hoenig, A. Hirano, A. Levine and N.R. Ghatak (1970) The early development and fine structure of allergic adrenalitis. Lab. Invest. 22 198-205.
68. T.A. Howlett (1997) An assessment of optimal hydrocortisone replacement therapy. Clin. Endocrinol. (Oxf.) 46 263-268.
69. E.S. Husebye, G. Gebre-Medhin, T. Thuomi, J. Perheentupa, M. Landin-Olsson, J. Gustafsson, F. Rorsman and O. Kampe (1997) Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 82 147-150.
70. W.J. Irvine and E.W. Barnes (1975) Addison's disease, ovarian failure and hypoparathyroidism. Clin. Endocrinol. Metab. 4 379-434.
71. R. Jackson, A.M. McNicol, M. Farquarson and A.K. Foulis (1988) Class II MHC expression in normal adrenal cortex and cortical cell in autoimmune Addison's disease. J. Pathol. 155 113-120.
72. D.L. Jacobson, S.J. Gange, N.R. Rose and N.M.H. Graham (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84 223-243.
73. T. Kamradt and N.A. Mitchinson (2001) Tolerance and autoimmunity. N. Engl. J. Med. 344 655-664.
74. C.R. Kannan (1988) Addison's disease. C.R. Kannan (Eds) The Adrenal Gland London: Plenum
75. J. Kaufman (1984) Diseases of the adrenal cortex of dogs and cats. Mod. Vet. Pract. 65 513-516.
76. P. Kendall-Taylor, A. Lambert, R. Mitchell and W.R. Robertson (1988) Antibody that blocks stimulation of cortisol secretion by adrenocorticotrophic hormone in Addison's disease. Br. Med. J. 296 1489-1491.
77. E.L. Khoury, L. Hammond, G.F. Bottazzo and D. Doniach (1981) Surface-reactive antibodies to human adrenal cells in Addison's disease. Clin. Exp. Immunol. 45 48-55.
78. W. Kiaer and J.O. Rytter Norgaard (1969) Granulomatous hypophysitis and thyroiditis with lymphocytyc adrenalitis. Acta Pathol. Microbiol. Scand. 76 229.
79. P.P. Kintzer and M.E. Peterson (1994) Diagnosis and management of primary spontaneous hypoadrenocorticism (Addison's disease) in dogs. Sem. Vet. Med. Surg. 9(3), 148-152.
80. C.A. Koch (2004) Adrenal cortex physiology. L. Martini (Eds) Encyclopedia of Endocrine Disease San Diego, CA: Elsevier
81. M.F. Kong and W. Jeffocoate (1994) Eighty-six cases of Addison's disease. Clin. Endocrinol. 41 757-761.
82. K. Krohn, R. Uibo, E. Aavik, P. Peterson and K. Savilhati (1992) Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17-α-hydroxylase. Lancet 339 770-773.
83. S. Laureti, A.M. De Bellis, V.I. Muccitelli, F. Calcinaro, A. Bizzaro, R. Rossi, A. Bellastella, F. Santeusanio and A. Falorni (1998) Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfuncion in subjects with preclinical Addison's disease. J. Clin. Endocrinol. Metab. 83 3507-3511.
84. S. Laureti, L. Vecchi, F. Santeusanio and A. Falorni (1999) Is the prevalence of Addison's disease understimated? J. Clin. Endocrinol. Metab. 84 1762.
85. S. Laureti, E. Arvat, P. Candeloro, L. Di Vito, E. Ghigo, F. Santeusanio and A. Falorni (2000) Low dose (1 g) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease. Clin. Endocrinol. 53 107-115.
86. S. Levine and E.J. Wenk (1968) The production and passive transfer of allergic adrenalitis. Am. J. Pathol. 52 41-53.
87. R.S. Liblau, S.M. Singer and H.O. McDevitt (1995) Th1 and Th2 CD+T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16 34-38.
88. D. Lin, L. Zhang, E. Chiao and W.L. Miller (1994) Modeling and mutagenesis of the active site of human P450c17. Mol. Endocrinol. 8 392-402.
89. C. Little, C. Marshall and J. Downs (1989) Addison's disease in the dog. Vet. Rec. 124(17), 469-470.
90. K. Løvs and E.S. Husebye (2002) High prevalence and increasing incidence of Addison's disease in western Norway. Clin. Endocrinol. 56 787-791.
91. A.S. Mason, T.W. Meade, J.A. Lee and J.N. Morris (1968) Epidemiological and clinical picture of Addison's disease. Lancet 2 744-747.
92. J.D. McIntyre Gass (1962) The syndrome of keratoconjunctivitis, superficial moniliasis, idiopathic hypoparathyroidism and Addison's disease. Am. J. Ophthalmol. 54 660-674.
93. A.M. McNicol (1986) Class II MHC expression in the adrenal cortex. Lancet 2 1282.
94. A.M. McNicol and P. Laidler (1996) The adrenal gland and extra-adrenal paraganglia. P.D. Lewis (Eds) Endocrine System Edinburgh: Churchill Livingstone
95. J. Morgan, C. Betterle, R. Zanchetta, C. Dal Pra, S. Chen, B. Rees Smith and J. Furmaniak (2000) Direct evidence that steroid 21-hydroxylase (21-OH) is the major antigen recognized by adrenal cortex autoantibodies (ACA). J. Endocrinol. 167(Suppl), OC19.
96. F. Muscatelli, T.M. Strom, A.P. Walker, E. Zanaria, D. Recan, A. Meindl, B. Bardoni, S. Guioni, G. Zehetner and W. Rabl (1994) Mutations in the DAX-1 gene give rise to both x-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372 672-676.
97. A.G. Myhre, D.A. Undelien, K. Lovas, S. Uhlving, B.G. Nedrebo, K.J. Fougner, T. Trovik, J.I. Sorheim and E.S. Husebye (2002) Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II association related to clinical features. J. Clin. Endocrinol. Metab. 87 618-623.
98. J. Nerup (1974) Addison's disease—clinical studies. A report of 108 cases. Acta Endocrinol. 76 121-141.
99. J. Nerup and G. Bendixen (1969) Anti-adrenal cellular hypersensitivity in Addison's disease. 2 Correlation with clinical and serological findings. Clin. Exp. Immunol. 5 341-353.
100. J. Nerup, V. Andersen and G. Bendixen (1970) Antiadrenal cellular hypersensitivity in Addison's disease. IV. In vivo and in vitro investigations of the mitochondrial faraction. Clin. Exp. Immunol. 6 733.
101. M. Neufeld and R.M. Blizzard (1980) Polyglandular autoimmune diseases. A. Pinchera, D. Doniach, G.F. Fenzi, L. Baschieri (Eds) Symposium on Autoimmune Aspects of Endocrine Disorders New York: Academic Press
102. R. Nigam, E. Bhatia, D. Miao, A. Brozzetti, G.S. Eisenbarth and A. Falorni (2003) Prevalence of adrenal antibodies in Addison's disease among north Indian caucasians. Clin. Endocrinol. 59 593-598.
103. W. Oelkers (1996) Adrenal insufficiency. N. Engl. J. Med. 335 1206-1212.
104. W. Oelkers, S. Diederich and V. Bahr (1992) Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity and aldo. J. Clin. Endocrinol. Metab. 75 259-264.
105. D.N. Orth and W.J. Kavacs (1998) The adrenal cortex. J.D. Wilson, D.W. Foster, H.M. Kronenberg, P.R. Larse (Eds) Williams Textbook of Endocrinology 9th ed Philadelphia: W.B. Saunders
106. T.J. Pelkey, H.F. Frierson Jr., S.E. Mills and M.H. Stoler (1998) The alpha subunit of inhibin in adrenal cortical neoplasia. Mod. Pathol. 11 516-524.
107. M.E. Peterson, D.S. Greco and D.N. Orth (1989) Primary hypoadrenocorticism in ten cats. J. Vet. Intern. Med. 3 55-58.
108. P. Peterson and K.J.E. Krohn (1994) Mapping of B cell epitopes on steroid 17-α-hydroxylase, an autoantigen in autoimmune polyglandular syndrome type 1. Clin. Exp. Immunol. 98 104-109.
109. P. Peterson, J. Perheentupa and K.J.E. Krohn (1996) Detection of candidal antigens in autoimmune polyglandular syndrome type I. Clin. Diagn. Lab. Immunol. 3 290-294.
110. P. Peterson, R. Uibo, J. Peranen and K.J.E. Krohn (1997) Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type 1 (APS I) sera: further evidence for independent humoral immunity to P450 c17 and P450c21. Clin. Exp. Immunol. 107 335-340.
111. M. Petri and J. Nerup (1971) Addison's adrenalitis. Acta Path. Microbiol. Scand. 79 381-388.
112. J. Picado-Leonard and W.L. Miller (1987) Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20, lyase): similarity with the gene for P450c21. DNA Cell. Biol. 6 439-448.
113. S.L. Rabinowe, R.A. Jackson, R.G. Dluhy and G.H. Williams (1984) Ia-positive T lymphocytes in recently diagnosed idiopathic Addison's disease. Am. J. Med. 77 597-601.
114. B. Rees Smith and J. Furmaniak (1995) Editorial: adrenal and gonadal autoimmune diseases. J. Clin. Endocrinol. Metab. 80 1502-1505.
115. D. Sadek and M. Schaer (1996) Atypical Addison's disease in the dog: a retrospective survey of 14 cases. J. Am. Anim. Hosp. Assoc. 32 159-163.
116. Y.S. Salim, V. Faber, A. Wiik, P.L. Andersewn, M. Hoier-Madsen and S. Mouritsen (1988) Anti-corticosteroid antibodies in AIDS patients. Acta Pathol. Microbiol. Immunol. Scand. 96 889-894.
117. H. Sasano, M. Nose and N. Sasano (1989) Lectin histochemistry in adrenocortical hyperplasia and neoplasm with emphasis on carcinoma. Arch. Pathol. Lab. Med. 113 68-72.
118. H. Sasano, S. Miyazaki, T. Sawai, N. Sasano, H. Nagura, H. Funahashi, M. Aiba and H. Demura (1992) Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. Mod. Pathol. 5 23-29.
119. H. Sasano, T. Suzui, S. Shizawa, K. Kato and H. Natura (1994) Transforming growth factor alpha, epidernal growth factor and epidermal growth factor receptor in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization. Mod. Pathol. 7 741-746.
120. F. Skoldberg, G.M. Portela-Gomes, L. Grimelius, G. Nilsson, J. Perheentupa, C. Betterle, E.S. Husebye, J. Gustafsson, A. Ronnblom, F. Rorsman and O. Kampe (2003) Histidine decarboxylase is a novel autoantigen of enterochromaffin-like cells in autoimmune polyendocrine syndrome type 1. J. Clin. Endocrinol. Metab. 88 1445-1452.
121. Y. Song, E.L. Connor, A. Muir, J.X. She, B. Zorovich, D. Derovanesian and N. Maclaren (1994) Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease. J. Clin. Endocrinol. Metab. 78 1108-1112.
122. F. Sotsiu, G.F. Bottazzo and D. Doniach (1980) Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin. Exp. Immunol. 39 97-111.
123. J.W. Steiner, B. Langer, D.L. Schatz and R. Volpé (1960) Experimental immunolgic adrenal injury: a response to injections of autologous and homologous adrenal antigens in adjuvant. J. Exp. Med. 112 187.
124. P.M. Stewart, J. Corrie, J.R. Seckl, C.R. Edwards and P.L. Padfield (1988) A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet 1 1208-1210.
125. J. Stonehewer and S. Tasker (2001) Hypoadrenocroticism in a cat. J. Small Anim. Pract 42 186-190.
126. R. Takayanagi, K. Miura, H. Nakagawa and H. Nawata (2000) Epidemiological study of adrenal gland disorders in Japan. Biomed. Pharmacother. 54 164-168.
127. H. Tanaka, M.S. Perez, M. Powell, J.F. Sandres, J. Sawicka, S. Chen, L. Prentice, T. Asawa, C. Betterle, M. Volpato, B. Rees Smith and J. Furmaniak (1997) Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipations assay. J. Clin. Endocrinol. Metab. 82 1440-1446.
128. S. Tasker, A.D. MacKay and A.H. Sparkes (1999) Case report, A case of feline primary hypoadrenocorticism. J. Felin. Med. Surg. 1 257-260.
129. F. Thiebaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan and M.C. Willingham (1987) Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84 7735-7738.
130. A. Trousseau (1856) Bronze Addison's disease. Arch. Gen. Med. 8 478-485.
131. M.V. Verghese, F.E. Ward and G.S. Eisenbarth (1980) Decreased suppressor cell activity in patients with polyglandular failure. Clin. Res. 28 270A.
132. R. Volpé (1994) Autoimmune endocrinopathies: aspects of pathogenesis and the role of immune assays in investigation and management. Clin. Chem. 40 2132-2145.
133. C.A. Wardle, A.P. Weetman, R. Mitchell, N. Peers and W.R. Robertson (1993) Adrenocorticotropic hormone receptor-blocking immunoglobulins in serum from patients with Addison's disease: a re-examination. J. Clin. Endocrinol. Metab. 77 750-753.
134. N. Wedlock, T. Asawa, A. Baumann-Antczak, B. Rees Smith and J. Furmaniak (1993) Autoimmune Addison's disease. Analysis of autoantibody sites on human steroid 21-hydroxylase. FEBS Lett. 332 123-126.
135. O. Werdelin and E. Witebsky (1970) Experimental allergic rat adrenalitis, a study on its elicitation and lymphokinetics. Lab. Invest. 23 136-143.
136. O. Werdelin, G. Wick and R.T. McCluskey (1971) The fate of newly formed lymphocytes migration from an antigen-stimulated lymph node in rats with allergic adrenalitis. Lab. Invest. 25 279-286.
137. G.H. Williams and R.G. Dluhy (1998) Disease of the adrenal cortex. A.S. Fauci, E. Braunwald, K.J. Isselbacher, J.D. Wilson, J.B. Martin, D.L. Kasper, S.L. Hanser, D.L. Longo,(Eds) Harrison's Principles of Internal Medicine 14th ed New York: McGraw-Hill
138. A.C. Willis and F.P. Vince (1997) The prevalence of Addison's disease in Coventry, UK. Postgrad. Med. J. 73 286-288.
139. R.C. Wilson, A.B. Mercado, K.C. Cheng and M.I. New (1995) Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J. Clin. Endocrinol. Metab. 80 2322-3239.
140. O. Winqvist, F.A. Karlsson and O. Kampe (1992) 21-hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 339 1559-1562.
141. O. Winqvist, J. Gustafsson, F. Rorsman, F.A. Karlsson and O. Kampe (1993) Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J. Clin. Invest. 92 2377-2385.
142. O. Winqivist, A. Soderbergh and O. Kampe (1996) The autommune basis of adrenal cortical destruction in Addison's disease (review). Mol. Med. Today 2 282-289.
143. E. Witebsky and F. Milgrom (1962) Immunological studies on adrenal glands: II. Immunization with adrenals of the same species. Immunology 5 67-78.
144. N.M. Wulfraat, H.A. Drexhage, G.F. Bottazzo, W.M. Wiersinga, P. Jeucken and R. Van der Gaag (1989) Immunoglobulins of patients with idiopathic Addison's disease block the in vitro action of adrenocotropin. J. Clin. Endocrinol. Metab. 69 231-238.
145. L. Yu, K.W. Brewer, S. Gates, A. Wu, T. Wang, S.R. Babu, P.A. Gottlieb, B.M. Freed, J. Noble, H.A. Erlich, J. Rewers and G.S. Eisenbarth (1999) DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J. Clin. Endocrinol. Metab. 84 328-335.